Cargando…

A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe

AIM: To determine the clinical profile, burden of risk factors, and quality of care among patients hospitalized for an acute myocardial infarction (AMI) with special focus on gender differences. METHODS: The study included 256 AMI patients admitted to the Coronary Care Unit of “Mother Teresa” hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Myftiu, Sokol, Sulo, Enxhela, Burazeri, Genc, Sharka, Ilir, Shkoza, Artan, Sulo, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707925/
https://www.ncbi.nlm.nih.gov/pubmed/26718760
http://dx.doi.org/10.3325/cmj.2015.56.542
_version_ 1782409382015795200
author Myftiu, Sokol
Sulo, Enxhela
Burazeri, Genc
Sharka, Ilir
Shkoza, Artan
Sulo, Gerhard
author_facet Myftiu, Sokol
Sulo, Enxhela
Burazeri, Genc
Sharka, Ilir
Shkoza, Artan
Sulo, Gerhard
author_sort Myftiu, Sokol
collection PubMed
description AIM: To determine the clinical profile, burden of risk factors, and quality of care among patients hospitalized for an acute myocardial infarction (AMI) with special focus on gender differences. METHODS: The study included 256 AMI patients admitted to the Coronary Care Unit of “Mother Teresa” hospital in Tirana during 2013-2014. We obtained information on patients’ demographic data, AMI characteristics, complications (heart failure [HF] and ventricular fibrillation [VF]), risk factors and medication use prior and during the AMI hospitalization. Age-adjusted Poisson regression analyses were applied to explore gender differences (women vs men) with regard to clinical profile and quality of care and results are expressed as incidence rate ratios (IRR). RESULTS: 55.4% of patients had ≥3 risk factors, 44.5% developed HF, and 5.7% developed VF. Only 40.4% of patients received all 4 medication classes (beta-blockers, angiotensin-converting-enzyme inhibitor/angiotensin receptor blockers, statins, and aspirin) and 46.4% had revascularization. Significantly more women than men were obese, (P = 0.042) had diabetes, (P = 0.001) developed HF (P < 0.001) or experienced a VF episode (P < 0.001). After adjusting for age, differences with regard to obesity (IRR = 2.17; 95% confidence interval [CI] 1.15-4.09), diabetes (IRR = 1.35; 95% CI 1.07-1.71), HF (IRR = 1.32; 95% CI 1.02-1.74) and VF (IRR = 2.82; 95% CI 1.07-7.43) remained significant. There were no differences with regard to individual drug classes taken. However, women had fewer revascularization procedures than men (IRR = 0.65; 95% CI 0.43-0.98). CONCLUSION: Women were found to have more unfavorable clinical profile, higher complication rates, and underutilization of therapy, which may be influenced by socioeconomic differences between genders and lead to a differential prognosis.
format Online
Article
Text
id pubmed-4707925
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Croatian Medical Schools
record_format MEDLINE/PubMed
spelling pubmed-47079252016-01-14 A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe Myftiu, Sokol Sulo, Enxhela Burazeri, Genc Sharka, Ilir Shkoza, Artan Sulo, Gerhard Croat Med J Clinical Science AIM: To determine the clinical profile, burden of risk factors, and quality of care among patients hospitalized for an acute myocardial infarction (AMI) with special focus on gender differences. METHODS: The study included 256 AMI patients admitted to the Coronary Care Unit of “Mother Teresa” hospital in Tirana during 2013-2014. We obtained information on patients’ demographic data, AMI characteristics, complications (heart failure [HF] and ventricular fibrillation [VF]), risk factors and medication use prior and during the AMI hospitalization. Age-adjusted Poisson regression analyses were applied to explore gender differences (women vs men) with regard to clinical profile and quality of care and results are expressed as incidence rate ratios (IRR). RESULTS: 55.4% of patients had ≥3 risk factors, 44.5% developed HF, and 5.7% developed VF. Only 40.4% of patients received all 4 medication classes (beta-blockers, angiotensin-converting-enzyme inhibitor/angiotensin receptor blockers, statins, and aspirin) and 46.4% had revascularization. Significantly more women than men were obese, (P = 0.042) had diabetes, (P = 0.001) developed HF (P < 0.001) or experienced a VF episode (P < 0.001). After adjusting for age, differences with regard to obesity (IRR = 2.17; 95% confidence interval [CI] 1.15-4.09), diabetes (IRR = 1.35; 95% CI 1.07-1.71), HF (IRR = 1.32; 95% CI 1.02-1.74) and VF (IRR = 2.82; 95% CI 1.07-7.43) remained significant. There were no differences with regard to individual drug classes taken. However, women had fewer revascularization procedures than men (IRR = 0.65; 95% CI 0.43-0.98). CONCLUSION: Women were found to have more unfavorable clinical profile, higher complication rates, and underutilization of therapy, which may be influenced by socioeconomic differences between genders and lead to a differential prognosis. Croatian Medical Schools 2015-12 /pmc/articles/PMC4707925/ /pubmed/26718760 http://dx.doi.org/10.3325/cmj.2015.56.542 Text en Copyright © 2015 by the Croatian Medical Journal. All rights reserved. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Science
Myftiu, Sokol
Sulo, Enxhela
Burazeri, Genc
Sharka, Ilir
Shkoza, Artan
Sulo, Gerhard
A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe
title A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe
title_full A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe
title_fullStr A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe
title_full_unstemmed A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe
title_short A higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in Albania, a transitional country in Southeastern Europe
title_sort higher burden of metabolic risk factors and underutilization of therapy among women compared to men might influence a poorer prognosis: a study among acute myocardial ifarction patients in albania, a transitional country in southeastern europe
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707925/
https://www.ncbi.nlm.nih.gov/pubmed/26718760
http://dx.doi.org/10.3325/cmj.2015.56.542
work_keys_str_mv AT myftiusokol ahigherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT suloenxhela ahigherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT burazerigenc ahigherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT sharkailir ahigherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT shkozaartan ahigherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT sulogerhard ahigherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT myftiusokol higherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT suloenxhela higherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT burazerigenc higherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT sharkailir higherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT shkozaartan higherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope
AT sulogerhard higherburdenofmetabolicriskfactorsandunderutilizationoftherapyamongwomencomparedtomenmightinfluenceapoorerprognosisastudyamongacutemyocardialifarctionpatientsinalbaniaatransitionalcountryinsoutheasterneurope